MTOR and metabolic dysfunction-associated steatotic liver disease: Marcondes-de-Castro et al. highlighted the critical role of AMPK and mTOR pathways in maintaining hepatic homeostasis, proposing that targeting these mechanisms may offer therapeutic benefits for NAFLD management [44].